Shelf life mass polymerizable polycycloolefin compositions as optical materials

US11230566B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11230566-B2
Application numberUS-202117140247-A
CountryUS
Kind codeB2
Filing dateJan 4, 2021
Priority dateJan 2, 2020
Publication dateJan 25, 2022
Grant dateJan 25, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments in accordance with the present invention encompass compositions encompassing a latent organo-ruthenium compound and a pyridine compound along with one or more monomers which undergo ring open metathesis polymerization (ROMP) when said composition is exposed to suitable actinic radiation to form a substantially transparent film. Surprisingly, the compositions are very stable at ambient conditions to temperatures up to 80° C. for several days and undergo mass polymerization when subject only to actinic radiation. Accordingly, compositions of this invention are useful in various opto-electronic applications, including as 3D printing materials, coatings, encapsulants, fillers, leveling agents, among others.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising: a) one or more monomers of formula (I): wherein: m is an integer 0, 1 or 2; R 1 , R 2 , R 3 and R 4 are the same or different and each independently selected from the group consisting of hydrogen, halogen, methyl, ethyl, linear or branched (C 3 -C 16 )alkyl, perfluoro(C 1 -C 12 )alkyl, hydroxy(C 1 -C 16 )alkyl, (C 3 -C 12 )cycloalkyl, (C 6 -C 12 )bicycloalkyl, (C 7 -C 14 )tricycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 6 )alkyl, perfluoro(C 6 -C 10 )aryl, perfluoro(C 6 -C 10 )aryl(C 1 -C 6 )alkyl, tri(C 1 -C 6 )alkoxysilyl and a group of formula (A): —Z-Aryl  (A) wherein: Z is a bond or a group selected from the group consisting of: (CR 5 R 6 ) a , O(CR 5 R 6 ) a , (CR 5 R 6 ) a O, (CR 5 R 6 ) a —O—(CR 5 R 6 ) b , (CR 5 R 6 ) a —O—(SiR 5 R 6 ) b , (CR 5 R 6 ) a —(CO)O—(CR 5 R 6 ) b , (CR 5 R 6 ) a —O(CO)—(CR 5 R 6 ) b , (CR 5 R 6 ) a —(CO)—(CR 5 R 6 ) b , where a and b are integers which may be the same or different and each independently is 1 to 12; R 5 and R 6 are the same or different and each independently selected from the group consisting of hydrogen, methyl ethyl, linear or branched (C 3 -C 6 )alkyl, hydroxy, methoxy, ethoxy, linear or branched (C 3 -C 6 )alkyloxy, acetoxy, (C 2 -C 6 )acyl, hydroxymethyl, hydroxyethyl, linear or branched hydroxy(C 3 -C 6 )alkyl, phenyl and phenoxy; Aryl is phenyl or phenyl substituted with one or more of groups selected from the group consisting of methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, hydroxy, methoxy, ethoxy, linear or branched (C 3 -C 6 )alkyloxy, acetoxy, (C 2 -C 6 )acyl, hydroxymethyl, hydroxyethyl, linear or branched hydroxy(C 3 -C 6 )alkyl, phenyl and phenoxy; b) an organo-ruthenium compound selected from the group consisting of a compound of formula (II) and a compound of formula (III): wherein L is P(R) 3 , wherein each R is independently selected from the group consisting of methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, (C 3 -C 8 )cycloalkyl and (C 6 -C 10 )aryl; R 7 and R 8 are the same or different and each independently selected from the group consisting of hydrogen, methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, methoxy, ethoxy and linear or branched (C 3 -C 6 )alkyloxy; R 9 is selected from the group consisting of methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, (C 6 -C 10 )aryl and (C 6 -C 10 )aryl(C 1 -C 6 )alkyl; Ar 1 , Ar 2 and Ar 3 are the same or different and each independently selected from the group consisting of substituted or unsubstituted phenyl, substituted or unsubstituted biphenyl and substituted or unsubstituted naphthyl, wherein each of said substituents are independently selected from the group consisting of methyl, ethyl and linear or branched (C 3 -C 6 )alkyl; c) a compound selected from the group consisting of: a compound of formula (IVa), a compound of formula (IVb), a compound of formula (Va), a compound of formula (Vb) and a compound of formula (Vc): wherein n is an integer from 0 to 4; x is an integer from 2 to 5; y is an integer from 4 to 12; each R 10 is independently selected from the group consisting of hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl and tert-butyl; R 11 is selected from the group consisting of methyl, ethyl, linear or branched (C 3 -C 6 )alkyl, (C 6 -C 10 )aryl, methoxy, ethoxy, linear or branched (C 3 -C 6 )alkoxy, (C 6 -C 10 )aryloxy and halogen; each R 12 is independently selected from the group consisting of iso-propyl, iso-butyl tert-butyl, iso-amyl and branched (C 5 -C 8 )alkyl; and d) a photoactive compound of formula (VI): wherein Y is halogen; and R 30 and R 31 are the same or different and independently of each other selected from the group consisting of hydrogen, methyl, ethyl, linear or branched (C 3 -C 12 )alkyl, (C 3 -C 12 )cycloalkyl, (C 6 -C 12 )bicycloalkyl, (C 7 -C 14 )tricycloalkyl, (C 6 -C 10 )aryl, (C 6 -C 10 )aryl(C 1 -C 3 )alkyl, (C 1 -C 12 )alkoxy, (C 3 -C 12 )cycloalkoxy, (C 6 -C 12 )bicycloalkoxy, (C 7 -C 14 )tricycloalkoxy, (C 6 -C 10 )aryloxy(C 1 -C 3 )alkyl and (C 6 -C 10 )-aryloxy; and said composition is in a clear liquid form at room temperature. 2. The composition according to claim 1 , wherein said composition comprises first and second monomer of formula (I) distinct from each other and one of said first and second monomers having a refractive index of at least 1.5 and viscosity below 100 centipoise, and wherein said first monomer is completely miscible with said second monomer to form a clear solution. 3. The composition according to claim 1 , wherein said composition forms a substantially transparent film when exposed to suitable actinic radiation. 4. The composition according to claim 3 , wherein said film has a transmission of equal to or higher than 90 percent of the visible light. 5. The composition according to claim 3 , wherein said film has a transmission of equal to or higher than 95 percent of the visible light. 6. The composition according to claim 1 , wherein the monomer of formula (I) is selected from the group consisting of: 7. The composition according to claim 1 , wherein: L is selected from the group consisting of P(iPr) 3 , P(tert-Bu) 3 , PCy 3 and PPh 3 ; R 7 and R 8 are the same or different and each independently selected from the group consisting of hydrogen, methyl, ethyl and isopropyl; R 9 is selected from the group consisting of hydrogen, methyl, ethyl and isopropyl; Ar 1 , Ar 2 and Ar 3 are the same or different and each independently selected from the group consisting of phenyl, 2,6-dimethylphenyl, 2,4-dimethylphenyl, 2,6-diethylphenyl, 2,6-di(isopropyl)phenyl and 2,4,6-trimethylphenyl. 8. The composition according to claim 7 , wherein the organo-ruthenium compound of formula (II) or organo-ruthenium compound of formula (III) is selected from the group consisting of: 9. The composition according to claim 1 , wherein: n is an integer from 0 to 2; each R 10 is independently selected from the group consisting of methyl, ethyl, iso-propyl and tert-butyl; and R 11 is selected from the group consisting of methyl, ethyl, iso-propyl, tert-butyl, phenyl, methoxy, ethoxy, phenoxy, fluorine and chlorine. 10. The composition according to claim 1 , wherein the compound of formula (IVa) is selected from the group consisting of: N,N-dimethylpyridin-4-amine; N,N-diethylpyridin-4-amine; N,N-diisopropylpyridin-4-amine; N,N-di-tert-butylpyridin-4-am

Assignees

Inventors

Classifications

  • Characterised by the use of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain (C08J2307/00 - C08J2357/00, C08J2361/00 take precedence); Derivatives of such polymers · CPC title

  • Manufacture of films or sheets · CPC title

  • Photovoltaic applications · CPC title

  • Ring opening metathesis polymerisation [ROMP] · CPC title

  • of Os, Ir, Pt, Ru, Rh, Pd · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11230566B2 cover?
Embodiments in accordance with the present invention encompass compositions encompassing a latent organo-ruthenium compound and a pyridine compound along with one or more monomers which undergo ring open metathesis polymerization (ROMP) when said composition is exposed to suitable actinic radiation to form a substantially transparent film. Surprisingly, the compositions are very stable at ambie…
Who is the assignee on this patent?
Promerus Llc
What technology area does this patent fall under?
Primary CPC classification C08G61/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).